Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A clinical study testing mobile videoconferencing between a physician and stroke patient being transported to the hospital was found to be 98 percent as accurate was a bedside visit.
To increase participation in clinical trials by Hispanics, Texas A&M University is partnering with Driscoll Children’s Hospital based in Corpus Christi, Texas, to create a new center dedicated to providing better healthcare to Hispanic populations.
For many people, dealing with the ins and outs of the healthcare system is exhausting. Physicians and hospitals don’t always work well together so it’s left to patients to maneuver their own care.
The University of Illinois Hospital in Chicago is trying a new approach to cut down on the cost of care for Medicaid “superutilizers” who are frequently admitted to emergency rooms: Give them an apartment instead.
In the latest report on patient engagement by TeleHealth Services, a provider of patient engagement, only 20 percent of hospitals have an interactive patient engagement system while the other 80 percent still rely on paper handouts.
Hermann Health System, the largest non-profit healthcare system in Texas, headquartered in Houston, is buying neighboring hospital Memorial Hermann Northeast Hospital, a 255-bed facility.
The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns.
If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?
